BridgeBio secures FDA approval for Attruby in ATTR-CM treatment, demonstrating 42% reduction in mortality and hospitalizations. First therapy with 90% TTR stabilization effectiveness.
HII's Ingalls Shipbuilding reaches key milestone in construction of advanced Arleigh Burke-class destroyer Sam Nunn (DDG 133), featuring next-gen radar and combat systems.
Defence Therapeutics secures $1.47M via convertible debentures at 8% interest, settles previous debt through share conversion. New debentures mature in 2025 with $0.60 conversion price.
NUBURU receives NYSE American non-compliance notice due to insufficient independent directors on Audit Committee. Company has until Jan 2025 to meet listing requirements.
SHARC International Systems completes debt settlement through share issuance, converting $47,500 of debt into equity with a four-month statutory hold period for issued shares.
Tech giants AWS, Google & Microsoft reach settlement with I&M Power for massive data center projects in Indiana, including $1.5M annual community support & cost protections for existing customers.
Wrap Technologies issues notice to disregard their recent announcement about their go-forward strategy and new Virginia facility. Get the latest update on this retraction.
Portillo's leadership team announces participation in key investor events including Furey Research, Morgan Stanley, and ICR conferences, with presentations from November through January.
MYND Life Sciences strengthens its position by converting $800K in debt to equity and appointing former Otsuka Canada executive Lana Hoogenboom to advance its depression biomarker test.
Boron One Holdings announces warrant incentive program, reducing exercise price from $0.12 to $0.06 and offering additional warrants to raise up to $694,560 in working capital.
